Log Type Authored on Log Message Log Node Authored by
User created User created Анонимен
Newsletter opened Opened Estratégias na esquizofrenia - Aderente à adesão Анонимен
Newsletter clicked Clicked https://za.progress.im/en/content/what-are-roles-abnormal-metabolism-and-inflammation-mood-disorders Анонимен
Newsletter opened Opened Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind South Africa Анонимен
User created User created Анонимен
User created User created Анонимен
User created User created Анонимен
Newsletter opened Opened Convite Lundbeck Webinar Internacional Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Анонимен
User created User created Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now Анонимен
OWA Status israel@progress.im manually updating trust level from 1 to 5 Анонимен
Newsletter clicked Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now Анонимен
Newsletter opened Opened Анонимен
OWA Status Updating trust level from 1 to 2 Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Анонимен
User created User created Анонимен
OWA Status Updating trust level from 1 to 2 Анонимен
OWA Status Updating trust level from 1 to 4 Анонимен
Log Type Authored on Log Message Log Node Authored by
User created User created Анонимен
Newsletter opened Opened Estratégias na esquizofrenia - Aderente à adesão Анонимен
Newsletter clicked Clicked https://za.progress.im/en/content/what-are-roles-abnormal-metabolism-and-inflammation-mood-disorders Анонимен
Newsletter opened Opened Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind South Africa Анонимен
User created User created Анонимен
User created User created Анонимен
User created User created Анонимен
Newsletter opened Opened Convite Lundbeck Webinar Internacional Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Анонимен
User created User created Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now Анонимен
OWA Status israel@progress.im manually updating trust level from 1 to 5 Анонимен
Newsletter clicked Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now Анонимен
Newsletter opened Opened Анонимен
OWA Status Updating trust level from 1 to 2 Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Анонимен
User created User created Анонимен
OWA Status Updating trust level from 1 to 2 Анонимен
OWA Status Updating trust level from 1 to 4 Анонимен